CryoSpray Ablation(tm)Thoracic Patient Registry
The proposed registry is a prospective, multi-center study of patients that are currently
undergoing CryoSpray Ablation™. A maximum of 50 investigational sites will participate in
The study population consists of patients who are being treated with the CryoSpray Ablation™
System for thoracic diseases. Enrolled subjects must have a signed consent form for data
Observational Model: Case-Only, Time Perspective: Prospective
Primary objectives of the study are to enable analysis of patient outcomes 2 years following final treatment and estimate the effectiveness of the device in eradicating, decreasing and downgrading of the diseases.
2 years post-treatment
William Krimsky, M.D.
Franklin Square Hospital Center
United States: Institutional Review Board